Drug Manufacturers - Specialty & Generic
Compare Stocks
2 / 10Stock Comparison
EMBC vs LFUS
Revenue, margins, valuation, and 5-year total return — side by side.
Hardware, Equipment & Parts
EMBC vs LFUS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Hardware, Equipment & Parts |
| Market Cap | $211M | $11.11B |
| Revenue (TTM) | $1.04B | $2.49B |
| Net Income (TTM) | $112M | $-40M |
| Gross Margin | 61.4% | 38.3% |
| Operating Margin | 27.7% | 2.8% |
| Forward P/E | 1.3x | 33.8x |
| Total Debt | $1.43B | $946M |
| Cash & Equiv. | $226M | $563M |
EMBC vs LFUS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 22 | May 26 | Return |
|---|---|---|---|
| Embecta Corp. (EMBC) | 100 | 10.7 | -89.3% |
| Littelfuse, Inc. (LFUS) | 100 | 177.1 | +77.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EMBC vs LFUS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EMBC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 1.31, yield 16.7%
- Rev growth -3.8%, EPS growth 20.9%, 3Y rev CAGR -1.5%
- Lower volatility, beta 1.31, current ratio 2.41x
LFUS is the clearest fit if your priority is long-term compounding.
- 315.2% 10Y total return vs EMBC's -87.6%
- 8.9% revenue growth vs EMBC's -3.8%
- +133.3% vs EMBC's -65.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.9% revenue growth vs EMBC's -3.8% | |
| Value | Lower P/E (1.3x vs 33.8x) | |
| Quality / Margins | 10.7% margin vs LFUS's -1.6% | |
| Stability / Safety | Beta 1.31 vs LFUS's 1.76 | |
| Dividends | 16.7% yield, 1-year raise streak, vs LFUS's 0.7% | |
| Momentum (1Y) | +133.3% vs EMBC's -65.9% | |
| Efficiency (ROA) | 10.3% ROA vs LFUS's -1.0%, ROIC 42.7% vs 1.0% |
EMBC vs LFUS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EMBC vs LFUS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
EMBC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LFUS is the larger business by revenue, generating $2.5B annually — 2.4x EMBC's $1.0B. EMBC is the more profitable business, keeping 10.7% of every revenue dollar as net income compared to LFUS's -1.6%. On growth, LFUS holds the edge at +18.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.0B | $2.5B |
| EBITDAEarnings before interest/tax | $316M | $227M |
| Net IncomeAfter-tax profit | $112M | -$40M |
| Free Cash FlowCash after capex | $174M | $390M |
| Gross MarginGross profit ÷ Revenue | +61.4% | +38.3% |
| Operating MarginEBIT ÷ Revenue | +27.7% | +2.8% |
| Net MarginNet income ÷ Revenue | +10.7% | -1.6% |
| FCF MarginFCF ÷ Revenue | +16.7% | +15.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -14.4% | +18.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.9% | +69.1% |
Valuation Metrics
EMBC leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, EMBC's 3.7x EV/EBITDA is more attractive than LFUS's 83.2x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $211M | $11.1B |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $11.5B |
| Trailing P/EPrice ÷ TTM EPS | 2.20x | -152.30x |
| Forward P/EPrice ÷ next-FY EPS est. | 1.26x | 33.80x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 3.72x | 83.23x |
| Price / SalesMarket cap ÷ Revenue | 0.20x | 4.66x |
| Price / BookPrice ÷ Book value/share | — | 4.53x |
| Price / FCFMarket cap ÷ FCF | 1.16x | 30.35x |
Profitability & Efficiency
EMBC leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), EMBC scores 6/9 vs LFUS's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | -1.6% |
| ROA (TTM)Return on assets | +10.3% | -1.0% |
| ROICReturn on invested capital | +42.7% | +1.0% |
| ROCEReturn on capital employed | +37.8% | +1.1% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | — | 0.39x |
| Net DebtTotal debt minus cash | $1.2B | $383M |
| Cash & Equiv.Liquid assets | $226M | $563M |
| Total DebtShort + long-term debt | $1.4B | $946M |
| Interest CoverageEBIT ÷ Interest expense | 39.48x | -0.93x |
Total Returns (Dividends Reinvested)
LFUS leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LFUS five years ago would be worth $17,565 today (with dividends reinvested), compared to $1,236 for EMBC. Over the past 12 months, LFUS leads with a +133.3% total return vs EMBC's -65.9%. The 3-year compound annual growth rate (CAGR) favors LFUS at 20.1% vs EMBC's -43.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -68.2% | +68.5% |
| 1-Year ReturnPast 12 months | -65.9% | +133.3% |
| 3-Year ReturnCumulative with dividends | -81.7% | +73.4% |
| 5-Year ReturnCumulative with dividends | -87.6% | +75.7% |
| 10-Year ReturnCumulative with dividends | -87.6% | +315.2% |
| CAGR (3Y)Annualised 3-year return | -43.3% | +20.1% |
Risk & Volatility
Evenly matched — EMBC and LFUS each lead in 1 of 2 comparable metrics.
Risk & Volatility
EMBC is the less volatile stock with a 1.31 beta — it tends to amplify market swings less than LFUS's 1.76 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LFUS currently trades 93.0% from its 52-week high vs EMBC's 22.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.31x | 1.76x |
| 52-Week HighHighest price in past year | $15.55 | $475.00 |
| 52-Week LowLowest price in past year | $3.55 | $188.08 |
| % of 52W HighCurrent price vs 52-week peak | +22.9% | +93.0% |
| RSI (14)Momentum oscillator 0–100 | 14.4 | 71.1 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 266K |
Analyst Outlook
Evenly matched — EMBC and LFUS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates EMBC as "Sell" and LFUS as "Buy". Consensus price targets imply 237.1% upside for EMBC (target: $12) vs -9.4% for LFUS (target: $400). For income investors, EMBC offers the higher dividend yield at 16.69% vs LFUS's 0.65%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Sell | Buy |
| Price TargetConsensus 12-month target | $12.00 | $400.00 |
| # AnalystsCovering analysts | 4 | 11 |
| Dividend YieldAnnual dividend ÷ price | +16.7% | +0.7% |
| Dividend StreakConsecutive years of raises | 1 | 16 |
| Dividend / ShareAnnual DPS | $0.59 | $2.89 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.7% | +0.2% |
EMBC leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). LFUS leads in 1 (Total Returns). 2 tied.
EMBC vs LFUS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is EMBC or LFUS a better buy right now?
For growth investors, Littelfuse, Inc.
(LFUS) is the stronger pick with 8. 9% revenue growth year-over-year, versus -3. 8% for Embecta Corp. (EMBC). Embecta Corp. (EMBC) offers the better valuation at 2. 2x trailing P/E (1. 3x forward), making it the more compelling value choice. Analysts rate Littelfuse, Inc. (LFUS) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EMBC or LFUS?
On forward P/E, Embecta Corp.
is actually cheaper at 1. 3x.
03Which is the better long-term investment — EMBC or LFUS?
Over the past 5 years, Littelfuse, Inc.
(LFUS) delivered a total return of +75. 7%, compared to -87. 6% for Embecta Corp. (EMBC). Over 10 years, the gap is even starker: LFUS returned +315. 2% versus EMBC's -87. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EMBC or LFUS?
By beta (market sensitivity over 5 years), Embecta Corp.
(EMBC) is the lower-risk stock at 1. 31β versus Littelfuse, Inc. 's 1. 76β — meaning LFUS is approximately 34% more volatile than EMBC relative to the S&P 500.
05Which is growing faster — EMBC or LFUS?
By revenue growth (latest reported year), Littelfuse, Inc.
(LFUS) is pulling ahead at 8. 9% versus -3. 8% for Embecta Corp. (EMBC). On earnings-per-share growth, the picture is similar: Embecta Corp. grew EPS 20. 9% year-over-year, compared to -172. 5% for Littelfuse, Inc.. Over a 3-year CAGR, EMBC leads at -1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EMBC or LFUS?
Embecta Corp.
(EMBC) is the more profitable company, earning 8. 8% net margin versus -3. 0% for Littelfuse, Inc. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMBC leads at 30. 5% versus 1. 6% for LFUS. At the gross margin level — before operating expenses — EMBC leads at 62. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EMBC or LFUS more undervalued right now?
On forward earnings alone, Embecta Corp.
(EMBC) trades at 1. 3x forward P/E versus 33. 8x for Littelfuse, Inc. — 32. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMBC: 237. 1% to $12. 00.
08Which pays a better dividend — EMBC or LFUS?
All stocks in this comparison pay dividends.
Embecta Corp. (EMBC) offers the highest yield at 16. 7%, versus 0. 7% for Littelfuse, Inc. (LFUS).
09Is EMBC or LFUS better for a retirement portfolio?
For long-horizon retirement investors, Embecta Corp.
(EMBC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (16. 7% yield). Littelfuse, Inc. (LFUS) carries a higher beta of 1. 76 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EMBC: -87. 6%, LFUS: +315. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EMBC and LFUS?
These companies operate in different sectors (EMBC (Healthcare) and LFUS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: EMBC is a small-cap deep-value stock; LFUS is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.